These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Schindler G; Capper D; Meyer J; Janzarik W; Omran H; Herold-Mende C; Schmieder K; Wesseling P; Mawrin C; Hasselblatt M; Louis DN; Korshunov A; Pfister S; Hartmann C; Paulus W; Reifenberger G; von Deimling A Acta Neuropathol; 2011 Mar; 121(3):397-405. PubMed ID: 21274720 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemistry is highly sensitive and specific for detection of BRAF V600E mutation in pleomorphic xanthoastrocytoma. Ida CM; Vrana JA; Rodriguez FJ; Jentoft ME; Caron AA; Jenkins SM; Giannini C Acta Neuropathol Commun; 2013 May; 1():20. PubMed ID: 24252190 [TBL] [Abstract][Full Text] [Related]
8. Prospective evaluation of two screening methods for molecular testing of metastatic melanoma: Diagnostic performance of BRAF V600E immunohistochemistry and of a NRAS-BRAF fully automated real-time PCR-based assay. Vallée A; Denis-Musquer M; Herbreteau G; Théoleyre S; Bossard C; Denis MG PLoS One; 2019; 14(8):e0221123. PubMed ID: 31415669 [TBL] [Abstract][Full Text] [Related]
9. Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells. Koelsche C; Wöhrer A; Jeibmann A; Schittenhelm J; Schindler G; Preusser M; Lasitschka F; von Deimling A; Capper D Acta Neuropathol; 2013 Jun; 125(6):891-900. PubMed ID: 23435618 [TBL] [Abstract][Full Text] [Related]
10. Rapid BRAF mutation tests in patients with advanced melanoma: comparison of immunohistochemistry, Droplet Digital PCR, and the Idylla Mutation Platform. Bisschop C; Ter Elst A; Bosman LJ; Platteel I; Jalving M; van den Berg A; Diepstra A; van Hemel B; Diercks GFH; Hospers GAP; Schuuring E Melanoma Res; 2018 Apr; 28(2):96-104. PubMed ID: 29232304 [TBL] [Abstract][Full Text] [Related]
11. Role of diffusion weighted imaging for differentiating cerebral pilocytic astrocytoma and ganglioglioma BRAF V600E-mutant from wild type. Ramaglia A; Tortora D; Mankad K; Lequin M; Severino M; D'Arco F; Löbel U; Benenati M; de Leng WWJ; De Marco P; Milanaccio C; Rossi A; Morana G Neuroradiology; 2020 Jan; 62(1):71-80. PubMed ID: 31667545 [TBL] [Abstract][Full Text] [Related]
12. Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAF(V600E) mutation and expression. Chappé C; Padovani L; Scavarda D; Forest F; Nanni-Metellus I; Loundou A; Mercurio S; Fina F; Lena G; Colin C; Figarella-Branger D Brain Pathol; 2013 Sep; 23(5):574-83. PubMed ID: 23442159 [TBL] [Abstract][Full Text] [Related]
15. [BRAF V600E mutation and clinicopathologic characteristics in 250 cases of brain tumors associated with epilepsy]. Qi XL; Yao K; Duan ZJ; Bian Y; Ma Z; Piao YS; Gong LP Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):664-670. PubMed ID: 30220118 [No Abstract] [Full Text] [Related]
16. Multi-center evaluation of the novel fully-automated PCR-based Idylla™ BRAF Mutation Test on formalin-fixed paraffin-embedded tissue of malignant melanoma. Melchior L; Grauslund M; Bellosillo B; Montagut C; Torres E; Moragón E; Micalessi I; Frans J; Noten V; Bourgain C; Vriesema R; van der Geize R; Cokelaere K; Vercooren N; Crul K; Rüdiger T; Buchmüller D; Reijans M; Jans C Exp Mol Pathol; 2015 Dec; 99(3):485-91. PubMed ID: 26407762 [TBL] [Abstract][Full Text] [Related]
17. Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma. Pagès M; Beccaria K; Boddaert N; Saffroy R; Besnard A; Castel D; Fina F; Barets D; Barret E; Lacroix L; Bielle F; Andreiuolo F; Tauziède-Espariat A; Figarella-Branger D; Puget S; Grill J; Chrétien F; Varlet P Brain Pathol; 2018 Jan; 28(1):103-111. PubMed ID: 27984673 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemistry with Anti-BRAF V600E (VE1) Mouse Monoclonal Antibody is a Sensitive Method for Detection of the BRAF V600E Mutation in Colon Cancer: Evaluation of 120 Cases with and without KRAS Mutation and Literature Review. Dvorak K; Higgins A; Palting J; Cohen M; Brunhoeber P Pathol Oncol Res; 2019 Jan; 25(1):349-359. PubMed ID: 29127628 [TBL] [Abstract][Full Text] [Related]
20. The usefulness of a novel fully automated PCR-based Idylla test for detection of the BRAF V600E mutation in thyroid tissue: comparison with PNA-clamping PCR, real-time PCR and pyrosequencing. Yeo MK; Jung MK; Lee SY; Lee YM; Hur GM; Kim JM J Clin Pathol; 2017 Mar; 70(3):260-265. PubMed ID: 27543599 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]